Penetration of vancomycin into human lung tissue

Area of Science:

• Pharmacology
• Infectious Diseases
• Critical Care Medicine

Background:

• Vancomycin is a critical antibiotic for treating serious Gram-positive bacterial infections.
• Optimizing vancomycin dosing is essential to ensure therapeutic efficacy and minimize resistance.
• Lung tissue penetration is crucial for treating pneumonia and other respiratory tract infections.

Purpose of the Study:

• To evaluate vancomycin concentrations in lung tissue following a standard 1-hour intravenous infusion.
• To determine if standard vancomycin dosing achieves concentrations above the minimum inhibitory concentration (MIC) for staphylococci in lung tissue over a 12-hour interval.

Main Methods:

• Thirty patients received a 1g intravenous infusion of vancomycin over 1 hour.
• Lung tissue and serum vancomycin concentrations were measured at various time points post-infusion (1, 2, 3-4, 6, and 12 hours).
• Lung tissue to serum concentration ratios were calculated.

Main Results:

• Mean vancomycin lung tissue concentrations declined significantly over 12 hours post-infusion.
• Lung tissue concentrations were below the MIC for susceptible staphylococci in several patients at 6 and 12 hours.
• Lung tissue to serum concentration ratios ranged from 0.24 to 0.41.

Conclusions:

• A 1-hour intravenous infusion of 1g vancomycin does not achieve sustained therapeutic concentrations in lung tissue.
• Alternative administration methods, such as continuous infusion, should be considered for optimizing vancomycin therapy in lung infections.
• Further research into optimal vancomycin dosing strategies for respiratory infections is warranted.